AU2019384164A1 - Manufacture of virus - Google Patents

Manufacture of virus Download PDF

Info

Publication number
AU2019384164A1
AU2019384164A1 AU2019384164A AU2019384164A AU2019384164A1 AU 2019384164 A1 AU2019384164 A1 AU 2019384164A1 AU 2019384164 A AU2019384164 A AU 2019384164A AU 2019384164 A AU2019384164 A AU 2019384164A AU 2019384164 A1 AU2019384164 A1 AU 2019384164A1
Authority
AU
Australia
Prior art keywords
virus
culture
recombinant oncolytic
host cells
bioreactor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019384164A
Other languages
English (en)
Inventor
Susan Nicole HOLLEY
August Allen RENSHAW
Jackie Vasseur
Michelle Catherine VENDEL
Katy WACK
Paul Andrew Wright
Mingrui Zhang
Guangyu Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kalivir Immunotherapeutics Inc
Original Assignee
Kalivir Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kalivir Immunotherapeutics Inc filed Critical Kalivir Immunotherapeutics Inc
Publication of AU2019384164A1 publication Critical patent/AU2019384164A1/en
Assigned to KALIVIR IMMUNOTHERAPEUTICS, INC. reassignment KALIVIR IMMUNOTHERAPEUTICS, INC. Request for Assignment Assignors: WESTERN ONCOLYTICS LTD.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2019384164A 2018-11-21 2019-11-21 Manufacture of virus Abandoned AU2019384164A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862770577P 2018-11-21 2018-11-21
US62/770,577 2018-11-21
PCT/US2019/062643 WO2020106975A1 (en) 2018-11-21 2019-11-21 Manufacture of virus

Publications (1)

Publication Number Publication Date
AU2019384164A1 true AU2019384164A1 (en) 2021-06-03

Family

ID=70774620

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019384164A Abandoned AU2019384164A1 (en) 2018-11-21 2019-11-21 Manufacture of virus

Country Status (8)

Country Link
US (1) US20210277363A1 (enExample)
EP (1) EP3884044A4 (enExample)
JP (1) JP7625519B2 (enExample)
KR (1) KR20210093965A (enExample)
CN (1) CN113330111A (enExample)
AU (1) AU2019384164A1 (enExample)
CA (1) CA3120129A1 (enExample)
WO (1) WO2020106975A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116529382A (zh) * 2020-10-02 2023-08-01 吉恩勒克斯公司 由贴壁细胞在生物反应器中产生病毒
JP2026519561A (ja) * 2023-05-31 2026-06-16 コーニング インコーポレイテッド 固定床バイオリアクタにおける改善される細胞回収効率のための方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL131014A0 (en) 1997-01-31 2001-01-28 Schering Plough Corp Methods for cultivating cells and propagating viruses
DK1520008T3 (da) * 2002-07-09 2012-10-15 Baxter Int Medium frit for dyreprotein til dyrkning af celler
CN1922308A (zh) * 2004-02-23 2007-02-28 克鲁塞尔荷兰公司 病毒纯化方法
SI2032592T1 (sl) * 2006-06-12 2013-10-30 Cytos Biotechnology Ag Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov
AU2007347716B2 (en) * 2006-09-15 2013-06-20 Medimmune, Llc MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
US8003363B2 (en) * 2007-05-14 2011-08-23 Bavarian Nordic A/S Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
AU2008250596C1 (en) 2007-05-14 2010-11-25 Bavarian Nordic A/S Purification of Vaccinia virus- and recombinant Vaccinia virus-based vaccines
KR20110074563A (ko) * 2008-09-24 2011-06-30 메디뮨 엘엘씨 바이러스의 정제 방법
KR102022952B1 (ko) * 2011-08-05 2019-09-20 신라젠(주) 백시니아 바이러스의 생산을 위한 방법 및 조성물
US10851350B1 (en) * 2017-06-27 2020-12-01 Genelux Corporation Bioreactor production of virus from adherent cells

Also Published As

Publication number Publication date
CN113330111A (zh) 2021-08-31
JP2022508156A (ja) 2022-01-19
EP3884044A4 (en) 2022-08-31
WO2020106975A1 (en) 2020-05-28
EP3884044A1 (en) 2021-09-29
JP7625519B2 (ja) 2025-02-03
US20210277363A1 (en) 2021-09-09
KR20210093965A (ko) 2021-07-28
CA3120129A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
JP7227406B2 (ja) 細胞培養物を処理する方法およびシステム
JP2011524887A5 (enExample)
US20160176921A1 (en) Methods of purifying recombinant proteins
RU2021119421A (ru) Способы обработки текучей среды, содержащей рекомбинантный терапевтический белок, и их применение
JP6385559B2 (ja) 細胞培養体からのポリオウイルスの精製プロセス
US20210277363A1 (en) Manufacture of Virus
CN118974245A (zh) 纯化包膜病毒的方法
CN115141813A (zh) 一种高效去除宿主细胞残留蛋白的腺病毒纯化方法
CN104027800A (zh) 一种人用狂犬病疫苗的制备方法
KR102245547B1 (ko) 고밀도의 미정제 세포 배양 수거물의 정화를 위한 방법
JP2025118611A (ja) 接着細胞からのウイルスのバイオリアクター生成
US20260085294A1 (en) Process for producing a purified rhabdovirus from cell culture
CN115992101B (zh) 一种流感病毒裂解疫苗原液的制备方法
HK40058237A (en) Manufacture of virus
CN105316296A (zh) 一种纯化腺病毒颗粒的方法
JP2022533122A (ja) 透析濾過プロセスを使用した効率的な不純物除去
CN117660373A (zh) 一种慢病毒大规模纯化方法及其应用
CN112469821A (zh) 一种制备重组人凝血因子ⅷ的方法
CN121699879A (zh) 重组脊髓灰质炎病毒制备方法
CN103588871A (zh) 一种rhTRAIL菌体的分离纯化方法

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application